Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intracellular myocardial components refer to the collective internal structures of cardiomyocytes, including myofibrils, mitochondria, the sarcoplasmic reticulum, and various cytosolic proteins [DrugBank, PubMed]. These components are fundamental to the heart's ability to contract and maintain rhythmic electrical activity; myofibrils provide mechanical force, while mitochondria generate ATP through oxidative phosphorylation [PubMed]. The sarcoplasmic reticulum regulates calcium levels, which is crucial for excitation-contraction coupling, and disruption of these components is a hallmark of various cardiomyopathies and heart failure [PubMed]. In a pharmacological context, these components serve as the target for specific diagnostic radiopharmaceuticals, such as Technetium Tc-99m pyrophosphate, which localize in areas of myocardial damage [DrugBank, StatPearls]. Following an acute myocardial infarction, the loss of cell membrane integrity allows these agents to enter the cell and bind to calcium deposits (hydroxyapatite) and denatured proteins within the necrotic tissue [StatPearls]. This interaction is also utilized in the diagnosis of transthyretin cardiac amyloidosis, where the tracer binds to amyloid fibrils deposited within the myocardial interstitium and intracellular spaces [StatPearls]. While not a single molecular entity, these components are critical for maintaining cardiac function and serve as essential markers for diagnostic imaging [DrugBank, StatPearls].
Binding to calcium hydroxyapatite crystals and denatured proteins within necrotic or damaged myocardial cells [StatPearls, DrugBank].
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intracellular myocardial components.